SEARCH

SEARCH BY CITATION

References

  • 1
    Shukla VK, Tiwari SC, Roy SK. Biliary bile acids in cholelithiasis and carcinoma of the gallbladder. Eur J Cancer Prev 1993; 2: 155160.
  • 2
    Funabiki T, Suigiue K, Matsubara T, Amano H, Ochiai M. Bile acids and biliary carcinoma in pancreaticobiliary maljunction. Keio J Med 1991; 40: 118122.
  • 3
    Broome U, Lofberg R, Veress B, Ljusk SE. Primary sclerosing cholangitis and ulcerative colitis: Evidence for increased neoplastic potential. Hepatology 1995; 22: 14041408.
  • 4
    Oda D, Lee SP, Hayashi A. Long-term culture and partial characterization of dog gallbladder epithelial cells. Lab Invest 1991; 64: 682692.
  • 5
    Oda D, Savard CE, Nguyen TD, Eng L, Swenson ER, Lee SP. Dog pancreatic duct epithelial cells: Long-term culture and characterization. Am J Path 1996; 148: 977985.
  • 6
    Oda D, Savard CE, Eng L, Lee SP. The effect of N-methyl-N′-nitro-N-nitrosoguanidine (MNNG) on cultured dog pancreatic duct epithelial cells. Pancreas 1996; 12: 109116.
  • 7
    Comoglio PM, Di Renzo MF, Gaudino G, Ponzetto C, Prat M. Tyrosine Kinase and control of cell proliferation. Am Rev Respir Dis 1990; 142: S16S19.
  • 8
    Saggioro D, Ferrancini R, Di Renzo MF, Naldini L, Chieco-Bianchi L, Comoglio PM. Protein phosphorylation at tyrosine residues in v-abl transformed mouse lymphocytes and fibroblasts. Int J Cancer 1986; 37: 623628.
  • 9
    Purdum PP, Ulissi A, Hylemon PB, Shiffman ML, Moore EW. Cultured human gallbladder epithelia. Methods and partial characterization of a carcinoma-derived model. Laboratory Investigation 1993; 68: 345353.
  • 10
    Merrick DT, Blanton RA, Gown AM, McDougall JK. Altered expression of proliferation and differentiation markers in human papillomavirus 16 and 18 immortalized epithelial cells grown in organotypic culture. Am J Pathol 1992; 140: 167177.
  • 11
    Karnovski MJ. A formaldehyde-gluteraldehyde fixative of high osmolarity for use in electron microscopy [Abstract]. J Cell Biol 1965; 27: 137A.
  • 12
    Rabinovitch PS, O'Brien K, Simpson M, Callis JB, Hoehn H. Flow cytogenetics. High-resolution ploidy measurements in human fibroblast cultures. Cytogenet Cell Genet 1981; 29: 6576.
  • 13
    Pories SE, Weber TK, Simpson H, Greathead P, Steele G, Summerhayes IC. Immortalization and neoplastic transformation of normal rat colon epithelium: An in vitro model of colonic neoplastic progression. Gastroenterology 1993; 146: 13461355.
  • 14
    Kuver R, Savard CE, Oda D, Lee SP. Prostaglandin E generates intracellular cAMP and accelerates mucin secretion by cultured dog gallbladder epithelial cells. Am J Physiol 1994; 267: G998G1003.
  • 15
    Thomas G. Genetics and molecular biology of gastrointestinal cancer. In: AhlgreenJ, MacdonaldJ, eds. Gastrointestinal Oncology. Philadelphia: Lippincott, 1992: 559569.
  • 16
    Paraskeva C, Corfield AP, Harper S, Hague A, Audcent K, Williams AC. Colorectal carcinogenesis: Sequential steps in the in vitro immortalization and transformation of human colonic epithelial cells (review). Anti-cancer Res 1990; 10: 11891200.
  • 17
    Rhim JS. Neoplastic transformation of human epithelial cells in vitro. Anticancer Res 1989; 9: 13451366.
  • 18
    Druker BJ, Mamon HJ, Roberts TM. Oncogenes, growth factors, and signal transduction. NEJM 1989; 321: 13831390.
  • 19
    Kodama M, Kodama T, Kodama M. Is N-methyl-N′-nitro-N-nitrosoguanidine a hormonal carcinogen? (review). Anticancer Res 1991; 11: 941946.
  • 20
    Lee LW, Tsao MS, Grisham JW, Smith GJ. Emergence of neoplastic transformants spontaneously or after exposure to N-methyl-N′-nitro-N-nitrosoguanidine in populations of rat liver epithelial cells cultured under selective and nonselective conditions. Am J Path 1989; 135: 6371.
  • 21
    Orfao A, Ciudad J, Gonzalez M, Lopez A, Del-Mar-Abad M, Paz-Bouza JI, Cruz JJ, et al. Flow cytometry in the diagnosis of cancer. Scand J Clin Lab Invest Suppl 1995; 221: 145152.
  • 22
    Crissman JD, Visscher DW, Sarkar FH. Premalignant lesions of the upper aerodigestive tract: Biomarkers of genetic alterations, proliferation, and differentiation. J Cell Biochem Suppl 1993; 17F: 192198.
  • 23
    Giordano S, Di Renzo MF, Cirillo D, Naldini L, Chiado'Piat L, Comoglio PM. Proteins phosphorylated on tyrosine as markers of human tumor cell lines. Int J Cancer 1987; 39: 482487.
  • 24
    Kamps MP, Sefton BM. Identification of multiple novel polypeptide substrates of the v-src, v-yes, v-fps, v-ros, and v-erb-B oncogenic tyrosine protein kinases utilizing antisera against phosphotyrosine. Oncogene 1988; 2: 305315.
  • 25
    Motokura T, Arnold A. Cyclin D and oncogenesis. Curr Opin Genet Dev 1993; 3: 510.
  • 26
    Hunter T, Pines J. Cyclins and cancer : Cyclin D and CDK inhibitors come of age. Cell 1994; 79: 573582.
  • 27
    Wahlin T, Thornell E, Jivegard L, Svanvik J. Effects of intraluminal prostaglandin E2in vivo on secretory behavior and ultrastructural changes in mouse gallbladder epithelium. Gastroenterology 1988; 95: 16321635.
  • 28
    Klinkspoor JH, Kuver R, Savard CE, Oda D, Azzouz H, Tytgat GNJ, Groen AK, et al. Model bile and bile salts accelerate mucin secretion by cultured dog gallbladder epithelial cells. Gastroenterology 1995; 109: 264274.
  • 29
    Yedgar S, Eidelman O, Malden E, Roberts D, Etcheberrigaray R, Goping G, Fox C, et al. Cyclic AMP-independent secretion of mucin by SW1116 human colon carcinoma cells. Differential control by Ca2+ ionophore A23187 and arachidonic acid. Biochem J 1992; 283: 421426.
  • 30
    Hofler P, Wehrle I, Bauer G. TGF-β induces an inhibitory effect of normal cells directed against transformed cells. Int J Cancer 1993; 54: 125130.
  • 31
    Barnard JA, Lyons RM, Moses HL. The cell biology of transforming growth factor beta. Biochem Biophys Acta 1990; 1032: 7987.
  • 32
    Massague J. The transforming-growth factor beta family. Ann Rev Cell Biol 1990; 6: 597641.
  • 33
    Sporn MB, Roberts AB. Transforming growth factor-β: Recent progress and new challenges. J Cell Biol 1990; 119: 10171021.
  • 34
    Geng Y, Weinberg RA. Transforming growth factor b effects on expression of G1 cyclins and cyclin-dependent protein kinases. Proc Natl Acad Sci U S A 1993; 90: 1031510319.
  • 35
    Laiho M, DeCaprio JA, Ludlow JW, Livingston DM, Massague J. Growth inhibition of TGF -b linked suppression of retinoblastoma protein phosphorylation. Cell 1990; 62: 175185.
  • 36
    Howe PH, Draetta G, Leof EB. Transforming growth factor b 1 inhibition of p34 cdc2 phosphorylation and histone H1 kinase activity is associated with G1/S-phase growth arrest. Mol Cell Biol 1991; 11: 11851194.
  • 37
    Manning AM, Williams AC, Game SM, Paraskeva C. Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor b (TGF -b): conversion of adenoma cell line to a tumorigenic phenotype is accompanied by a reduced response to the inhibitory effect of TGF-β. Oncogene 1991; 6: 14711476.
  • 38
    Cofffey RJ Jr., Sipes NJ, Bascom CC, Graves-Deal R, Pennington CY, Weissmann BE, Moses HL. Growth modulation of mouse keratinocytes by transforming growth factors. Cancer Res 1988; 48: 15961602.
  • 39
    Game SM, Stone A, Matthews JB, Scully C, Prime SS. Differentiation of malignant oral rat keratinocytes reflects changes in EGF and TGF- b receptor expression but not growth factor dependence. Carcinogenesis 1991; 12: 409416.
  • 40
    Knabbe C, Lippmann ME, Wakefield LM, Flanders FC, Kasid A, Derynck R, Dickson RB. Evidence that transforming growth factor- b is a hormonally regulated negative growth factor in human breast cancer cells. Cell 1987; 48: 417428.
  • 41
    McMahon JB, Richard WL, del Campo AA, Song MH, Thorgeirsson SS. Differential effects of transforming growth factor- b on proliferation of normal and malignant rat liver cells in culture. Cancer Res 1986; 46: 46654671.
  • 42
    Masui T, Wakefield LM, Lechner JF, LaVeck MA, Sporn MB, Harris CC. Type beta transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells. Proc Natl Acad Sci U S A 1986; 83: 24382442.
  • 43
    Kimchi A, Wang XF, Weiberg RA, Cheifetz S, Massague J. Absence of TGF-β receptors and growth inhibitory responses in retinoblastoma cells. Science 1988; 240: 196199.
  • 44
    Markowitz SD, Roberts AB. Tumor suppressor activity of the TGF -b pathway in human cancers. Cytokine Growth Factor Rev 1996; 7: 93102.
  • 45
    Chang SE. Human oral keratinocyte cultures and in vitro model systems for studying oral carcinogenesis. In: JohnsonNW, ed. Oral Cancer. Cambridge: Cambridge University Press, 1991: 340363.
  • 46
    Tahara E. Genetic alterations in human gastrointestinal cancers. The application to molecular diagnosis. Cancer 1995; 75: 14101417.
  • 47
    Wistuba II, Sugio K, Hung J, Kishimoto Y, Virmani AK, Roa I, Albores-Saavedra J, et al. Allele-specific mutations involved in the pathogenesis of endemic gallbladder carcinoma in Chile. Cancer Res 1995; 55: 25112515.
  • 48
    Teh M, Wee A, Raju GC. An immunohistochemical study of p53 protein in gallbladder and extrahepatic bile duct/ampullary carcinomas. Cancer 1994; 74: 15421545.
  • 49
    Watanabe M, Asaka M, Tanaka J, Kurosawa M, Kasai M, Miyazaki T. Point mutations of K-ras gene codon 12 in biliary tract tumors. Gastroenterology 1994; 107: 11471153.